8.3 C
New York
HomeTop Global NewsThis could be the next catalyst for Eli Lilly stock

This could be the next catalyst for Eli Lilly stock


Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain.

Cristina Arias | Cover | Getty Images

Shares of Eli Lilly (LLY) jumped Wednesday after the U.S. government gave the green light for the company’s blockbuster GLP-1 drug to be used as an obesity treatment. But the stock’s next big catalyst could likely come after a key competitor releases fresh trial data this weekend.



Source link

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here